Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

No reported Change in Working Capital figures are available to summarize.

Change in Working Capital history

Currency unavailable · from the cash flow

No Change in Working Capital data reported for this period type.

Change in Working Capital vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Change in Working Capital for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$16.17M USD———
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$10.9M USD-374.2%+68.3%—
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$9.02M USD+99.7%——
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$3.17M USD-22.0%+33.0%15.8%
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$2.34M USD+115.1%+11.0%1.1%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$677K USD-103.7%-60.2%—
GHRSGH Research PLCLTM Mar 2026$495.64K USD+217.7%——
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+38.8%+22.0%8.5%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.